Literature DB >> 15876468

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.

Adam Gordon1, Catriona A McLean, John S Pedersen, Michael J Bailey, Stuart K Roberts.   

Abstract

BACKGROUND/AIMS: Chronic hepatitis B (CHB) and C (CHC) are commonly associated with hepatic steatosis. The aims of this study were to investigate predictors of hepatic steatosis, and their impact on inflammation and fibrosis in CHB and CHC.
METHODS: Consecutive patients with either CHB or CHC who underwent a liver biopsy at The Alfred Hospital between April and September 2002 were included. Histological analysis of liver biopsies was performed by two hepatopathologists blinded to the clinical data.
RESULTS: Ninety-one patients were analysed including 17 patients with CHB and 74 with CHC. CHC genotype 3, C-peptide, glucose and waist circumference were independent predictors of extent of Brunt steatosis grade, while CHC genotype 3, C-peptide and waist circumference were independent predictors of microvesicular steatosis grade. Alcohol intake and age were predictors of hepatic fibrosis. There was a trend toward a correlation between both Brunt steatosis and microvesicular steatosis grades and fibrosis progression rate in CHC genotype non-3.
CONCLUSIONS: Hepatic steatosis is common in chronic hepatitis B and C, and is associated with waist circumference, glucose, C-peptide and chronic hepatitis C genotype 3. Steatosis grade appears to relate to hepatic fibrosis progression rate in chronic hepatitis C genotype non-3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876468     DOI: 10.1016/j.jhep.2005.01.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.

Authors:  Yu-Cheng Lin; Shu-Tin Hsiao; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

2.  Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.

Authors:  Ming-Lun Han; Wei-Jei Lee; Jung-Chien Chen; Kong-Han Ser; Shu-Chun Chen; Yi-Chih Lee
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

3.  Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients.

Authors:  A Y S Cheng; A P S Kong; V W S Wong; W Y So; H L Y Chan; C S Ho; C W K Lam; J S Tam; C C Chow; C S Cockram; J C N Chan; P C Y Tong
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

Review 4.  Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.

Authors:  Michał Kukla; Włodzimierz Mazur; Rafał J Bułdak; Krystyna Zwirska-Korczala
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

5.  Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B.

Authors:  Fehmi Ateş; Mehmet Yalnız; Saadet Alan
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

6.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

7.  Hepatic steatosis in chronic hepatitis B: a study of metabolic and genetic factors.

Authors:  Michael O Baclig; Karen G Reyes; Veni R Liles; Cynthia A Mapua; Mark Pierre S Dimamay; Juliet Gopez-Cervantes
Journal:  Int J Mol Epidemiol Genet       Date:  2018-04-05

8.  Morphometric analysis of hepatic steatosis in chronic hepatitis C infection.

Authors:  Alia Zubair; Shahid Jamal; Azhar Mubarik
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 9.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

10.  Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.

Authors:  G Forlani; P Di Bonito; E Mannucci; B Capaldo; S Genovese; M Orrasch; L Scaldaferri; P Di Bartolo; P Melandri; A Dei Cas; I Zavaroni; G Marchesini
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.